Olpasiran
Olpasiran is an siRNA therapeutic candidate that targets hepatic synthesis of lipoprotein (a) (Lp (a) ) . It is utilized in cardiovascular disease research to study Lp (a) inhibition, with applications in both in vitro mechanistic studies and in vivo preclinical models.
Product Specifications
CAS Number
2225856-03-9
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
